HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoCalendarPricing
Theme 		Help
Market News Stocks News ETF News Crypto News

Abeona Therapeutics Inc.

Contributing Author

Recent Articles by Abeona Therapeutics Inc.

Oct-30
Abeona Therapeutics Announces Permanent J-Code for ZEVASKYN (prademagene zamikeracel) ABEO GlobeNewswire
Oct-20
Abeona Therapeutics Appoints James A. Gow, MD, MBA, MS, MHCM, as Senior Vice President, Head of Clinical Development & Medical Affairs ABEO GlobeNewswire
Oct-13
Abeona Therapeutics Announces ABO-503 Gene Therapy for X-linked Retinoschisis (XLRS) Selected by FDA for Rare Disease Endpoint Advancement (RDEA) Pilot Program ABEO GlobeNewswire
Oct-01
Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) ABEO GlobeNewswire
Sep-02
Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) ABEO GlobeNewswire
Aug-29
Abeona Therapeutics Announces Participation in Upcoming Investor Conferences ABEO GlobeNewswire
Aug-14
Abeona Therapeutics Reports Second Quarter 2025 Financial Results and Corporate Updates ABEO GlobeNewswire
Aug-01
Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) ABEO GlobeNewswire
Jul-15
ZEVASKYN Gene Therapy Now Available at New Qualified Treatment Center in San Francisco Bay Area ABEO GlobeNewswire
Jul-02
Abeona Therapeutics Closes Sale of Rare Pediatric Disease Priority Review Voucher for $155 Million ABEO GlobeNewswire
Jul-01
Abeona Therapeutics Announces Option Exercise by Beacon Therapeutics for Novel AAV204 Capsid for Ophthalmology Gene Therapy ABEO GlobeNewswire
Jul-01
Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) ABEO GlobeNewswire
Jun-30
Abeona Therapeutics added to Membership of U.S. Small-cap Russell 2000 Index and Broad-market Russell 3000 Index ABEO GlobeNewswire
Jun-24
Abeona Therapeutics Announces Publication in The Lancet of Phase 3 VIITAL Study Data in Recessive Dystrophic Epidermolysis Bullosa ABEO GlobeNewswire
Jun-02
Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) ABEO GlobeNewswire
May-30
Abeona Therapeutics to Present at the Jefferies Global Healthcare Conference ABEO GlobeNewswire
May-15
Abeona Therapeutics Reports First Quarter 2025 Financial Results and Corporate Updates ABEO GlobeNewswire
May-14
UPDATE -- Abeona Therapeutics and Lurie Children's Open First Center for ZEVASKYN Gene Therapy to Treat Wounds in Painful Skin Disorder ABEO GlobeNewswire
May-14
Abeona Therapeutics and Lurie Children's Open First Center for ZEVASKYNTM Gene Therapy to Treat Wounds in Painful Skin Disorder ABEO GlobeNewswire
May-14
Abeona Therapeutics and Lurie Children's Open First Center for ZEVASKYN Gene Therapy to Treat Wounds in Painful Skin Disorder ABEO GlobeNewswire
May-12
Abeona Therapeutics Enters into Agreement to Sell Priority Review Voucher for $155 Million ABEO GlobeNewswire
May-07
Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) ABEO GlobeNewswire
Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 Finviz.com. All Rights Reserved.